THE "NEW" PROSTATE CANCER INFOLINK

There has been a positive plethora of news reports over the past 24 hours, starting with the very important issuance of the AUA/ASCO guideline on the potential use of 5-ARIs for the prevention of prostate cancer. This will be just the first of at least three groups of news reports today! This report deals with:

• A review of the role of IGF-I levels in development (and possible treatment) of prostate cancer
• The lack of “race-specific” differences in PSA levels based on ancestry
• An assessment of the feasibility of using genetic variants to test for prostate cancer risk
• The availability of a research grade (not a clinical) test for sarcosine levels in tissues
• Interim data on the investigational drug phenoxodiol … READ MORE …

Filed under: Diagnosis, Drugs in development, Risk | Tagged: ethnicity, IGF-I, insulin-like growth factor I, phenoxodiol, PSA, race, sarcosine research test, variants | Leave a comment »